Recent advances in developing modified C14 side chain pleuromutilins as novel antibacterial agents

Area of Science:

• Medicinal Chemistry
• Microbiology
• Drug Discovery

Background:

• Increasing antimicrobial resistance necessitates novel drug classes with distinct mechanisms of action.
• Pleuromutilins inhibit bacterial protein synthesis by targeting the ribosomal peptidyl transferase center.
• Emerging evidence suggests pleuromutilin derivatives also disrupt bacterial cell membranes, enhancing efficacy.

Purpose of the Study:

• To review recent advancements in pleuromutilin chemical structures.
• To analyze the antibacterial activities and structure-activity relationships of pleuromutilins.
• To focus on modifications of the C14 side chain for improved antimicrobial properties.

Main Methods:

• Literature review of recent studies on pleuromutilin derivatives.
• Analysis of structure-activity relationship data for C14 side chain modifications.
• Compilation of data on antibacterial spectrum and mechanisms of action.

Main Results:

• Structural modifications of the pleuromutilin C14 side chain significantly impact antibacterial activity.
• Combined mechanisms of action (protein synthesis inhibition and membrane disruption) contribute to enhanced efficacy.
• Several novel pleuromutilin derivatives demonstrate potent activity against resistant bacterial strains.

Conclusions:

• The C14 side chain is a critical determinant for pleuromutilin antibacterial potency and spectrum.
• Targeted modifications offer a viable strategy for developing next-generation pleuromutilin antibiotics.
• This review provides a foundation for future pleuromutilin drug development against resistant pathogens.